Andrew D. Krystal, MD
a:1:{i:0;s:100:"Psychiatry and Behavioral Science, University of California San Francisco, San Francisco, California";}
Narrative Review
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
June 2, 2025
Idiopathic hypersomnia, characterized by excessive daytime sleepiness (EDS), has an estimated population prevalence up to 1.5%. Psychiatric medications may exacerbate EDS and, conversely, idiopathic hypersomnia treatments may exacerbate psychiatric...
Article
Eszopiclone Treatment for Insomnia: Effect Size Comparisons in Patients With Primary Insomnia and Insomnia With Medical and Psychiatric Comorbidity
July 5, 2012
Review results from a post hoc analysis that compared the treatment effect size of eszopiclone 3 mg for insomnia in patients with a diagnosis of primary insomnia and in...
